C6K0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Avalo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 13.28 EUR -1.63% Market Closed

Market Cap: €240.8m

	Avalo Therapeutics Inc F:C6K0	US
	China Vanke Co Ltd F:18V0	CN
S	Sixt SE SWB:SIX3	DE
B	Brookside Energy Ltd XBER:8F3	AU
R	RS Group PLC DUS:ECN	UK
	Yangzijiang Shipbuilding Holdings Ltd SGX:BS6	CN

Profitability Summary

Avalo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

105%

Gross Margin is Increasing

81% > 100%

Negative Operating Margin

-123.602%

Negative 3Y Average Operating Margin

-18.716%

Declining Operating Margin

-146% > -123.602%

Negative Net Margin

-132.642%

Negative 3Y Average Net Margin

-21.305%

Declining Net Margin

-170% > -132.642%

Negative Free Cash Flow Margin

-87.217%

Negative 3Y Average Free Cash Flow Margin

-14.686%

Declining Free Cash Flow Margin

-121% > -87.217%

Negative ROE

-72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-281%

Declining ROIC

-151% > -428%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.